| 000 | 01850 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517165841.0 | ||
| 264 | 0 | _c20190128 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/CIRCULATIONAHA.117.028745 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSardella, Gennaro | |
| 245 | 0 | 0 |
_aPrasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus. _h[electronic resource] |
| 260 |
_bCirculation _c08 2017 |
||
| 300 |
_a602-604 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Letter; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xblood |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aPlatelet Function Tests |
| 650 | 0 | 4 |
_aPrasugrel Hydrochloride _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2Y12 _xblood |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aST Elevation Myocardial Infarction _xblood |
| 650 | 0 | 4 |
_aTicagrelor _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMancone, Massimo | |
| 700 | 1 | _aStio, Rocco Edoardo | |
| 700 | 1 | _aCavallo, Erika | |
| 700 | 1 | _aDi Roma, Angelo | |
| 700 | 1 | _aColantonio, Riccardo | |
| 700 | 1 | _aCalcagno, Simone | |
| 773 | 0 |
_tCirculation _gvol. 136 _gno. 6 _gp. 602-604 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCULATIONAHA.117.028745 _zAvailable from publisher's website |
| 999 |
_c27442674 _d27442674 |
||